Related Experiment Video
Updated: Jan 23, 2026

Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
Role of G protein-coupled receptor 1 in choriocarcinoma progression
Binbin Huang1,2, Wen Zhu1,2, Junlei Chang3
1Center for Reproduction and Health Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Abstract:
Choriocarcinoma is characterized by malignant proliferation and transformation of trophoblasts and is currently treated with systemic chemotherapeutic agents. The lack of specific targets for chemotherapeutic agents results in indiscriminate drug distribution. In our study, we aimed to delineate the mechanism by which G protein-coupled receptor 1 (GPR1) regulates the development of choriocarcinoma and thus investigated GPR1 as a prospective chemotherapeutic target. In this study, GPR1 expression levels were examined in several trophoblast cell lines. We found significantly higher GPR1 expression in choriocarcinoma cells (JEG3 and BeWo) than in normal trophoblast cells (HTR-8/SVneo). Additionally, we studied the role of GPR1 in choriocarcinoma in vitro and in vivo. GPR1 knockdown suppressed proliferation, invasion, and Akt and ERK phosphorylation in vitro and slowed tumor growth in vivo. Interestingly, GPR1 overexpression promoted increased proliferation, invasion, and Akt and ERK phosphorylation in vitro. Furthermore, we identified a specific GPR1-binding seven-amino acid peptide, LRH7-G3, that might also suppress choriocarcinoma in vitro and in vivo through phage display. Our study is the first to report that GPR1 may play a role in regulating choriocarcinoma progression through the Akt and ERK pathways. GPR1 could be a promising potential pharmaceutical target for choriocarcinoma.
Insights
G protein-coupled receptor 1 (GPR1) drives choriocarcinoma growth by promoting cell proliferation and invasion. Targeting GPR1, potentially with the peptide LRH7-G3, offers a promising therapeutic strategy for this cancer.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Choriocarcinoma is a malignant trophoblast tumor with limited targeted therapies.
- Current treatments lack specificity, leading to widespread drug distribution and side effects.
- Identifying novel therapeutic targets is crucial for improving choriocarcinoma treatment.
Purpose of the Study:
- To investigate the role of G protein-coupled receptor 1 (GPR1) in choriocarcinoma development.
- To evaluate GPR1 as a potential therapeutic target for choriocarcinoma.
- To identify specific GPR1-targeting agents for choriocarcinoma treatment.
Main Methods:
- GPR1 expression analysis in normal and choriocarcinoma trophoblast cell lines.
- In vitro and in vivo studies involving GPR1 knockdown and overexpression.
- Phage display to identify GPR1-binding peptides.
- Assessment of Akt and ERK phosphorylation pathways.
Main Results:
- GPR1 expression is significantly elevated in choriocarcinoma cells compared to normal trophoblasts.
- GPR1 knockdown inhibits choriocarcinoma cell proliferation, invasion, and tumor growth.
- GPR1 overexpression enhances choriocarcinoma cell proliferation and invasion.
- A GPR1-binding peptide, LRH7-G3, demonstrates potential in suppressing choriocarcinoma.
Conclusions:
- GPR1 plays a critical role in regulating choriocarcinoma progression via Akt and ERK signaling pathways.
- GPR1 represents a promising novel pharmaceutical target for choriocarcinoma therapy.
- The identified peptide LRH7-G3 warrants further investigation as a potential choriocarcinoma therapeutic agent.
Related Concept Videos
G-protein Coupled Receptors
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Role of Proteins in the Human Body
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Internal Receptors

